With many questions unanswered about Steve Jobs' medical leave of absence, Wall Street Journal 'ROI' columnist Brett Arends says the news is ominous for investors.
With many questions unanswered about Steve Jobs' medical leave of absence, Wall Street Journal 'ROI' columnist Brett Arends says the news is ominous for investors.